Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fresenius Medical Care AG & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

11/30/2020 | 05:57am EST

DGAP Total Voting Rights Announcement: Fresenius Medical Care AG & Co. KGaA / Total Voting Rights Announcement
Fresenius Medical Care AG & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

30.11.2020 / 11:56
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuer
Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 30.11.2020
  Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:
304664007



30.11.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

 
End of News DGAP News Service

1151485  30.11.2020 

fncls.ssp?fn=show_t_gif&application_id=1151485&application_name=news&site_id=zonebourse_sftp

© EQS 2020
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
01/22European ADRs Move Lower in Friday Trading
MT
01/19Cytosorbents' CytoSorb Blood Purification Technology Gets Nod from South Kore..
MT
01/18FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs maintains a Buy rating
MD
01/18FRESENIUS SE : Goldman Sachs maintains a Buy rating
MD
01/13FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from JP Morgan
MD
01/12FRESENIUS SE : Buy rating from JP Morgan
MD
01/11FRESENIUS MEDICAL CARE : Frenova enrolls patients in initiative to build world's..
PU
01/11FRESENIUS SE : Jefferies remains a Sell rating
MD
01/11FMC FRESENIUS MEDICAL CARE AG & CO K : Downgraded from Neutral to Sell by Jeffer..
MD
01/07European ADRs Move Higher in Thursday Trading
MT
More news
Financials (USD)
Sales 2020 21 457 M - -
Net income 2020 1 551 M - -
Net Debt 2020 14 728 M - -
P/E ratio 2020 16,1x
Yield 2020 1,71%
Capitalization 24 586 M 24 499 M -
EV / Sales 2020 1,83x
EV / Sales 2021 1,72x
Nbr of Employees 126 463
Free-Float 63,7%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 95,98 $
Last Close Price 84,24 $
Spread / Highest target 33,0%
Spread / Average Target 13,9%
Spread / Lowest Target -22,9%
EPS Revisions
Managers and Directors
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer